Subanesthetic #ketamine for Chronic Non-Cancer Pain: A Systematic Review of Evidence from Randomized Trials over the Past Two Decades (Zavaleta-Monestel, et al, 2026) “Overall, ketamine demonstrated significant short-term pain relief (p < 0.05), particularly in neuropathic conditions; however, the magnitude of this effect decreased progressively after the infusion ended. Reported adverse effects were mild and transient, with no evidence of severe toxicity.” https://www.mdpi.com/2813-1851/5/2/10 #chronicpain